Felice Shieh
Senior Director, Business Development and External Innovation Partnering
Professional Overview
Felice Shieh is a seasoned business development and strategic partnerships executive with extensive experience in the biopharmaceutical and life sciences industries. She currently serves as the Senior Director of Business Development and External Innovation Partnering at Johnson & Johnson, spearheading the company's efforts to identify and capitalize on emerging technologies and market opportunities through strategic alliances and investments.
Experience Summary
Current Role
As the Senior Director of Business Development and External Innovation Partnering at Johnson & Johnson, Felice is responsible for driving the company's business development strategy, cultivating partnerships with innovative startups and academic institutions, and evaluating investment opportunities that align with Johnson & Johnson's long-term growth objectives. She plays a crucial role in shaping the company's external innovation ecosystem and accelerating the translation of cutting-edge research into transformative healthcare solutions.
Career Progression
Felice's impressive career trajectory includes senior-level roles at various biopharmaceutical and investment firms. Prior to joining Johnson & Johnson, she served as the VP of Business Development and Alliance Management at Affini-T Therapeutics, where she spearheaded strategic partnerships and alliance management initiatives. She also held the position of Sr Director of Business Development and Investment Strategy at BeiGene, a global biotechnology company, where she was responsible for identifying and evaluating investment opportunities and strategic collaborations.
Earlier in her career, Felice worked as a Principal at Alexandria Venture Investments, the strategic venture capital arm of Alexandria Real Estate Equities, Inc., where she focused on sourcing and evaluating investment opportunities in the life sciences sector. She has also held business development and marketing roles at leading pharmaceutical companies, including Medivation/Pfizer, Onyx Pharmaceuticals (an Amgen subsidiary), Novartis, and Roche Molecular Systems.
Academic Background
Felice holds a Bachelor of Science degree in Molecular and Cell Biology from the University of California, Berkeley, and a Ph.D. in Molecular Genetics from the University of California, Los Angeles.
Areas of Expertise
- Business development and strategic partnerships
- External innovation and venture capital investments
- Pharmaceutical and biotechnology industry expertise
- Alliance management and portfolio optimization
- Cross-functional collaboration and stakeholder engagement
Professional Impact
Throughout her career, Felice has played a pivotal role in driving the growth and innovation of the companies she has worked for. Her strategic leadership, deep industry knowledge, and ability to forge successful collaborations have enabled her to identify and capitalize on emerging opportunities, accelerate the development of novel therapies, and create significant value for her organizations.
Conclusion
Felice Shieh is a highly accomplished business development and external innovation leader with a proven track record of driving success in the biopharmaceutical and life sciences industries. Her extensive experience, multifaceted expertise, and strategic vision position her as a valuable asset in her current role at Johnson & Johnson, where she continues to shape the company's external innovation agenda and forge strategic partnerships that advance the development of transformative healthcare solutions.
